The hospital is due to open early 2019; piling works are currently being carried out, and the group’s management is evaluating which contractors to use for the hospital building.
SINGAPORE (March 29): Maybank Kim Eng Research is reiterating its “buy” call on Raffles Medical Group at an unchanged price target of $1.70, after having hosted the private healthcare provider at its recent Invest ASEAN Singapore Conference.
In a report on Thursday, analyst John Cheong observes that the group’s China operations – specifically, its up-and-coming Shanghai hospital – is progressing well.
